Log In
Print
BCIQ
Print
Print this Print this
 

E-BPO (SGT-VD-54)

  Manage Alerts
Collapse Summary General Information
Company Sol-Gel Technologies Ltd.
DescriptionBenzoyl peroxide delivered with Sol-Gel's silica-based microencapsulation system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationRosacea
Indication DetailsTreat rosacea
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today